FDA approves Flyrcado (flurpiridaz F 18) radioactive diagnostic for enhanced diagnosis of coronary artery disease
GE HealthCare announced that the FDA has granted approval of Flyrcado (flurpiridaz F 18) injection, a first of its kind positron emission tomography myocardial perfusion imaging (PET MPI)… read more.
